Nvwm, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Nvwm, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$11.78 - $17.29 $17,882 - $26,246	-1,518 Reduced 55.73%	1,206 $20,000
Q3 2023 Oct 30, 2023	BUY	$11.69 - $15.02 $607 - $781	52 Added 1.95%	2,724 $31,000
Q2 2023 Aug 08, 2023	BUY	$11.5 - $18.08 $264 - $415	23 Added 0.87%	2,672 $35,000
Q1 2023 May 11, 2023	BUY	$14.34 - $21.05 $37,986 - $55,761	2,649 New	2,649 $43,000

327

94.1M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.33B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Nvwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Nvwm, LLC with notifications on news.